Compound ID | 868
S-31076
Class: Quinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | In comparison to sparfloxacin and tosufloxacin, S-31076 demonstrated improved activity against S. aureus and S. pyogenes, however, both sparfloxacin and tosufloxacin were more active against E. coli. |
| Description: | Senda H, Iwatani W, Watanuki Y, et al. Biological evaluation of a novel quinolone derivative with excellent activity against quinolone-resistant Staphylococcus aureus. 33rd-Intersci-Conf-Antimicrobial-Agents-Chemother 1993; 305. |
| Institute where first reported: | Kaken Pharmaceutical Co., Japan |
| Year first mentioned: | 1993 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/274248379 |
| Citation: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.